Palvella Therapeutics PVLA
NASDAQ PVLA
$140.88 +1.88 (+1.35%)
As of: Sep 30, 2026 · 11:50 AM EDT

Palvella Therapeutics (PVLA) Operating Expenses (2013 - 2026)

Updated

Palvella Therapeutics (PVLA) recorded Operating Expenses of $21.41 million in Q2 2026, up 131.4% from $9.25 million a year earlier and up 44.1% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Operating Expenses (2013 - 2026) Analysis & Trends

On a TTM basis, Palvella Therapeutics' Operating Expenses came in at $57.74 million as of Jun 30, 2026, up 117.5% year-over-year; for FY2025, it was $38.6 million, up 173.9% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of -9.4% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $14.1 million in FY2024 (+18.8%), $11.87 million in FY2023 (-82.9%), $69.38 million in FY2022 (-16.7%) and $83.25 million in FY2021 (+31.6%).
  • The Q2 2026 figure is the highest quarterly Operating Expenses since Q3 2023.
  • On a year-over-year basis, Operating Expenses has increased for six consecutive quarters, with growth averaging 137.4% over the last seven quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 347.5% in Q1 2025, against a decline of 89.9% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $14.86 million (Q1 2026), $11.3 million (Q4 2025) and $10.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Palvella Therapeutics 2.01 Bn 1.76 Bn - 21.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.41 Mn
Mar 31, 2026 14.86 Mn
Dec 31, 2025 11.30 Mn
Sep 30, 2025 10.18 Mn
Jun 30, 2025 9.25 Mn
Mar 31, 2025 7.87 Mn
Dec 31, 2024 4.37 Mn
Sep 30, 2024 5.06 Mn
Jun 30, 2024 2.91 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 -54.90 Mn
Sep 30, 2023 31.33 Mn
Jun 30, 2023 17.99 Mn
Mar 31, 2023 17.45 Mn
Dec 31, 2022 17.37 Mn
Sep 30, 2022 17.54 Mn
Jun 30, 2022 16.03 Mn
Mar 31, 2022 18.45 Mn
Dec 31, 2021 19.44 Mn
Sep 30, 2021 23.07 Mn
API Access

Palvella Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PVLA&period=max&api_key=YOUR_API_KEY